
Biography
Zekun Lyu is currently a research associate who focuses on the GPCR-based drug target development in type 2 diabetes and obesity by using multiple-transcriptomic and functional studies.

Zekun Lyu is currently a research associate who focuses on the GPCR-based drug target development in type 2 diabetes and obesity by using multiple-transcriptomic and functional studies.